Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis-Reference-Cited by-同舟云学术

Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis

Published:1997-12 Issue:6 Volume:226 Page:688-703
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:Annals of Surgery

Author:

Majno Pietro E.,Adam René,Bismuth Henri,Castaing Denis,Ariche Arie,Krissat Jinane,Perrin Hubert,Azoulay Daniel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference47 articles.

1. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis

2. Prognosis of unresectable hepatocellular carcinoma: An evaluation based on multivariate analysis of 90 cases

3. Hepatic artery embolization in 120 patients with unresectable hepatoma.

4. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

5. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion

Cited by 466 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Influence of Preoperative Trans Arterial Embolization (TAE) and Predictive Potential of Circulating Tumor Cells (CTCs) in Prognosis of Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2024-11

2. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults;Gut;2024-04-16

3. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation;Surgical Clinics of North America;2024-02

4. The Evolving Role of Transplant Oncology;Interdisciplinary Cancer Research;2024

5. Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects;BioScience Trends;2023-12-31